Barclays analyst Matt Miksic maintains $Stryker Corp (SYK.US)$ with a buy rating, and adjusts the target price from $402 to $418.
According to TipRanks data, the analyst has a success rate of 61.1% and a total average return of 7.0% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Stryker Corp (SYK.US)$'s main analysts recently are as follows:
The company delivered a notable performance surpassing expectations, characterized by 11.5% organic growth. This growth spanned across the majority of its significant divisions, accompanied by a rise in operating margins.
Stryker's Q3 outcomes exceeded expectations, showcasing double-digit growth in both revenue and earnings, accompanied by an expansion in operating margins.
Stryker's recent financial performance exceeded top-line expectations. Looking ahead to 2025, the company's growth is anticipated to be fueled by the introduction of new products, a series of approximately seven mergers and acquisitions that are poised to enhance growth, and the ongoing expansion of Mako, particularly with the addition of two new indications.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
巴克萊銀行分析師Matt Miksic維持$史賽克 (SYK.US)$買入評級，並將目標價從402美元上調至418美元。
根據TipRanks數據顯示，該分析師近一年總勝率為61.1%，總平均回報率為7.0%。
此外，綜合報道，$史賽克 (SYK.US)$近期主要分析師觀點如下：
該公司交付了超出預期的顯著業績，表現爲11.5%的有機增長。這種增長跨越了其大部分重要部門，並伴隨着營運利潤率的提升。
Stryker第三季度的業績超出預期，展示了營業收入和盈利的兩位數增長，伴隨着營運利潤率的擴張。
Stryker最近的財務表現超出了預期。展望2025年，公司的增長預計將受到新產品的推出，約七次併購的推動以提升增長，以及Mako的持續擴張，尤其是新增了兩個新適應症的增加。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
